HOW TO TECH UP What’s notable in “Anno 117” is that the tech tree is tied to the type of citizens players have. They begin ...

Having a temple opens up religion, and by choosing a Roman god, they gain access to ... I had to expand my Villa to house Julius Lupus, but to do that, I would need prestige, which was gained ...

Whether inspired by Latin, French, or folklore, these Harry Potter characters all have names that hint at their nature, ...

While the general prevalence of systemic lupus erythematosus (SLE) in India is reported as 3.2 per 100,000 population, specific data on various types of lupus within India are limited.

MEDICAL experts said there was an urgent need for greater public awareness on lupus, an often misunderstood autoimmune disease that affects many Filipinos. "Most Filipinos with lupus have a monthly ...

GROUP, WALKING TO END LUPUS. SATURDAY IS WORLD LUPUS DAY AND YOU CAN WALK TO END THE DISEASE IN MILWAUKEE COUNTY. JOINING ME NOW IS DANA WILSON, THE VOLUNTEER AND OUTREACH COORDINATOR FOR THE ...

Over 1.5 million people in the US and Canada have the chronic autoimmune disease lupus. it can trigger inflammation and pain throughout the body, leading to fatigue, joint pain, skin rashes ...

Lupus is an unpredictable and misunderstood autoimmune disease. It is difficult to diagnose, hard to live with, and a challenge to treat. Lupus has a range of symptoms, and strikes without warning.

Lupus is a chronic autoimmune disease. It can cause many different symptoms, including fever, fatigue, rashes, body aches, and confusion. While there’s no cure, symptoms can be managed with ...

This study is being conducted to evaluate the safety, tolerability, and ability to manufacture Descartes-08, an investigational mRNA CAR-T cell therapy, in people living with moderate to severe ...

A simple blood test could revolutionise treatment for lupus patients who do not respond to existing therapies, researchers say. Previous studies have shown that patients with treatment-resistant ...

The American College of Rheumatology last published recommendations for managing lupus nephritis (LN) in 2012. Since then, targeted treatments including belimumab (Benlysta) and voclosporin ...